Transdermal Lovastatin Enhances Fracture Repair in Rats
Open Access
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 23 (11), 1722-1730
- https://doi.org/10.1359/jbmr.080603
Abstract
Statins have been shown to stimulate BMP2 transcription and bone formation. This raises the possibility that they could be useful for enhancing rates of fracture repair. Observational studies in patients treated with oral statins for lipid‐lowering have been controversial. The likely reason for their inconsistent effects is that the statin concentration reaching the periphery was too low after oral administration to produce a reproducible biologic effect. Thus, we examined the effects of lovastatin (LV) given transdermally in a well‐described preclinical model of fracture repair. Effects on the healing fracture callus were assessed by biomechanical strength, radiographs, and quantitative morphology. LV was administered transdermally (TD) for 5 days after fracture in several doses (0.1–5 mg/kg/d) and compared with vehicle‐treated control rats and rats treated with LV by oral gavage (PO) at 5–25 mg/kg/d for 5 days from the day of fracture. Radiological evaluation of bones treated with TD LV showed enhanced fracture repair at 2 and 6 wk. BMD in the callus area at 6 wk was also increased in the TD group compared with vehicle‐treated controls (p < 0.05). The force required to break TD‐treated bones (0.1 mg/kg/d for 5 days) was 42% greater than vehicle‐treated controls (p < 0.02), and there was a 90% increase in stiffness (p < 0.01). PO LV at much higher doses (10 and 25 mg/kg/d) showed increased stiffness but no change in other biomechanical properties. By histological examination, a significant increase was also observed in the size of the callus, surrounding proliferating cell nuclear antigen–positive cells, and osteoblast and osteoclast number in TD‐treated rats compared with controls at day 8 after fracture (n = 6). In summary, we found that TD LV in low doses accelerates fracture healing, whereas 10‐fold the lipid‐lowering dose was required to produce any effect when it was administered orally. These studies provide valuable information on the potential of statins and TD delivery as a new and effective therapeutic modality in fracture repair.Keywords
This publication has 44 references indexed in Scilit:
- Locally applied Simvastatin improves fracture healing in miceBMC Musculoskeletal Disorders, 2007
- Application of Histomorphometric Methods to the Study of Bone RepairJournal of Bone and Mineral Research, 2005
- Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cellsJournal of Cellular Biochemistry, 2004
- Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytesJournal of Orthopaedic Science, 2003
- Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formationThe Journal of cell biology, 2002
- Early lesions of the labrum and acetabular cartilage in osteonecrosis of the femoral headThe Journal of Bone and Joint Surgery, 2002
- Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and ActivityThe American Journal of Pathology, 2001
- Compactin and Simvastatin, but Not Pravastatin, Induce Bone Morphogenetic Protein-2 in Human Osteosarcoma CellsBiochemical and Biophysical Research Communications, 2000
- Localization and Quantification of Proliferating Cells During Rat Fracture Repair: Detection of Proliferating Cell Nuclear Antigen by ImmunohistochemistryJournal of Bone and Mineral Research, 1997
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987